Optimi Health Corp. (TSE:OPTI) has released an update.
Optimi Health Corp., a Canadian GMP psychedelics manufacturer, has achieved a milestone by securing an Export Permit from Health Canada to ship its in-house produced MDMA to Tel Aviv University’s Institute for Psychedelic Research, marking its first international export. This move will support the Institute’s study on MDMA’s effects on alcohol addiction, showcasing Optimi’s role in furthering global psychedelic research and innovation.
For further insights into TSE:OPTI stock, check out TipRanks’ Stock Analysis page.
